News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,999 Results
Type
Article (87372)
Company Profile (759)
Press Release (771841)
Multimedia
Podcasts (169)
Webinars (28)
Section
Business (233032)
Career Advice (4137)
Deals (39789)
Drug Delivery (134)
Drug Development (91235)
Employer Resources (202)
FDA (18273)
Job Trends (17396)
News (397333)
Policy (39921)
Tag
Academia (3003)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (142)
Alzheimer's disease (1673)
Antibody-drug conjugate (ADC) (222)
Approvals (18283)
Artificial intelligence (477)
Autoimmune disease (67)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (52)
Breast cancer (473)
Cancer (3768)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (241)
CDC (55)
Cell therapy (669)
Cervical cancer (32)
Clinical research (75241)
Collaboration (1353)
Company closure (4)
Compensation (920)
Complete response letters (59)
COVID-19 (2950)
CRISPR (81)
C-suite (564)
Cystic fibrosis (132)
Data (4184)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (444)
Diagnostics (7082)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (228)
Drug pricing (183)
Drug shortages (36)
Duchenne muscular dystrophy (198)
Earnings (98729)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132735)
Executive appointments (978)
FDA (20662)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1224)
Gene editing (171)
Generative AI (45)
Gene therapy (534)
GLP-1 (1011)
Government (5375)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3181)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (183)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (636)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (536)
Lymphoma (258)
Machine learning (27)
Management (66)
Manufacturing (623)
MASH (136)
Medical device (14855)
Medtech (14876)
Mergers & acquisitions (22727)
Metabolic disorders (1137)
Multiple sclerosis (136)
NASH (23)
Neurodegenerative disease (221)
Neuropsychiatric disorders (59)
Neuroscience (2683)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (554)
Opinion (309)
Ovarian cancer (123)
Pain (161)
Pancreatic cancer (165)
Parkinson's disease (238)
Partnered (28)
Patents (408)
Patient recruitment (297)
Peanut (57)
People (66204)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23196)
Phase II (32678)
Phase III (24579)
Pipeline (2635)
Policy (291)
Postmarket research (3554)
Preclinical (10471)
Press Release (72)
Prostate cancer (191)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (649)
Real estate (7421)
Recruiting (78)
Regulatory (27918)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (14)
RNA editing (15)
RSV (70)
Schizophrenia (133)
Series A (202)
Series B (150)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (91)
The Weekly (107)
Vaccines (1034)
Venture capital (66)
Weight loss (391)
Women's health (58)
Worklife (21)
Date
Today (114)
Last 7 days (582)
Last 30 days (2437)
Last 365 days (33588)
2025 (25538)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50898)
Australia (8945)
California (9271)
Canada (2815)
China (871)
Colorado (395)
Connecticut (412)
Delaware (256)
Europe (116976)
Florida (1365)
Georgia (310)
Hawaii (3)
Idaho (67)
Illinois (802)
India (48)
Indiana (451)
Iowa (19)
Japan (307)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1258)
Massachusetts (6972)
Michigan (307)
Minnesota (556)
Mississippi (4)
Missouri (116)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2561)
New Mexico (32)
New York (2533)
North Carolina (1397)
North Dakota (10)
Northern California (4165)
Ohio (291)
Oklahoma (20)
Oregon (50)
Pennsylvania (1929)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3543)
Tennessee (148)
Texas (1450)
United States (34313)
Utah (275)
Virginia (243)
Washington D.C. (83)
Washington State (800)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,999 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Events
[Webinar] Mass Spec Enables More Definitive Biologics Drug Discovery and Optimization
Discover how Mass Spec enables high-resolution protein characterization and quantitative analysis for target validation and PK studies. Join our Oct 30 webinar packed with practical case studies and expert guidance. Reserve your spot now!
October 9, 2025
Press Releases
Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing
October 9, 2025
·
5 min read
Press Releases
Hemostemix Files for Ethics Approval of its Study of Vascular Dementia
October 9, 2025
·
12 min read
Press Releases
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It’s Board of Directors
October 9, 2025
·
4 min read
Press Releases
OS Therapies Provides Positive EMA Regulatory Update Following Positive Rapporteur Meeting
Overall survival recognized as key efficacy endpoint in osteosarcoma, where no standard of care exists Rapporteur highlights potential broader benefits of OST-HER2 in pulmonary and primary osteosarcoma settings, supported by translational canine data from the University of Pennsylvania
October 9, 2025
·
6 min read
Press Releases
American Society of Hematology Accepts Telo Genomics’ Abstract for Presentation at its 2025 Meeting and Exposition
Recognition highlights commercial potential of Telo’s telomere-based MRD technology in the growing precision oncology market
October 9, 2025
·
6 min read
Press Releases
U.S. Generic Drugs Market Size to Reach USD 196.90 Billion By 2034
October 9, 2025
·
1 min read
Press Releases
BioSpring Enters Strategic Partnership with Luxna Biotech to Offer Manufacture of Oligonucleotides with Luxna´s advanced XNA Amidites
October 9, 2025
·
1 min read
Mergers & Acquisitions
Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space
Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the indication earlier this year.
October 9, 2025
·
2 min read
·
Annalee Armstrong
Vaccines
ACIP Meeting Delayed Indefinitely; COVID-19 Vaccines Continue To Show Benefit in New Study
The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been postponed, with no new date specified. The delay comes as the VA published new research showing that COVID-19 shots prevented hospitalizations and death.
October 9, 2025
·
2 min read
·
Tristan Manalac
1 of 86,000
Next
